Objective: To assess the results with colchicine and prednisone as ini
tial single-drug therapy in patients with usual interstitial pneumonia
(UIP). Material and Methods: We reviewed the serial pulmonary functio
n test results in 22 patients with typical clinical and high-resolutio
n computed tomographic features of UIP who were treated with colchicin
e as initial single-agent therapy and compared them with a group of 22
historical patients with UIP of similar severity diagnosed by open-lu
ng biopsy who were given prednisone as initial single-drug therapy. Re
sults: No significant difference was detected in the rate of decline o
f pulmonary function or in the time to ''failure'' between the two stu
dy groups. A trend was suggested for more rapid decline of pulmonary f
unction in the prednisone-treated than in the colchicine-treated group
. The design of this study does not allow distinction between a possib
le beneficial effect of colchicine and a possible adverse effect relat
ed to weaning from high-dose prednisone. Colchicine was well tolerated
; few side effects other than mild diarrhea were noted in those patien
ts able to take the drug long enough to return for pulmonary function
testing at 3 months. In comparison, the side effects of prednisone wer
e more serious. and were not always reversible with cessation of thera
py. Conclusion: This study lends further support to the assumption tha
t colchicine may be a satisfactory and less hazardous substitute for p
rednisone in the treatment of patients with UIP.